drugset / Trial / NCT07363590

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

NCT07363590

Phase 1 Recruiting 21 enrolled Merck Sharp & Dohme LLC
RandomizedSequentialOpen-labelTreatment

Summary

This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).

Timeline

Start
2026-02-19
Primary completion
2029-07-16
Completion
2029-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-1045 Other / unclassified Intravenous